Lifestyle Changes for Non-Alcoholic Fatty Liver Disease
Prevention of NAFLD and CVD Through Lifestyle Intervention
- Age
- 45 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 300 (estimated)
- Sponsor
- Pontificia Universidad Catolica de Chile · Other
This trial is looking for people with non-alcoholic fatty liver disease (NAFLD) or gallstones. Participants will join a program focused on improving health through exercise and better nutrition.
You may be able to join if
- I have been diagnosed with non-alcoholic fatty liver disease.
- I have gallstones disease.
- I have a mild or moderate form of non-alcoholic fatty liver disease.
You may not be able to join if
- I have a significant health issue that affects my ability to exercise.
- I take medications that change my muscle mass.
- I have a history of hepatitis B or C.
- I take medications that can harm my liver.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityPrevention of non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) through lifestyle intervention (MAUCO+) is a clinical trial that aims to improve sarcopenia, aerobic capacity, body composition, and lipid profile, insulin resistance, cardiovascular risk, NAFLD, and maintain a healthier lifestyle. Through the implementation of physical activity and nutritional programs.
Loading trial locations…